Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last ¥6,880 JPY
Change Today +30.00 / 0.44%
Volume 326.5K
4555 On Other Exchanges
As of 2:00 AM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

sawai pharmaceutical co ltd (4555) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/25/15 - ¥7,900
52 Week Low
08/8/14 - ¥5,630
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SAWAI PHARMACEUTICAL CO LTD (4555)

Related News

No related news articles were found.

sawai pharmaceutical co ltd (4555) Related Businessweek News

No Related Businessweek News Found

sawai pharmaceutical co ltd (4555) Details

Sawai Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells, imports, and exports pharmaceutical products in Japan. The company offers prescription drugs in various formulations, such as tablets, oral dispersing tablets, capsules, granules, injections, tapes, ophthalmic/nasal solutions, syrups, etc. in the therapeutic areas of cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, chemotherapeutics, vitamins, anti-cancer, etc. The company also provides antihyperlipidemic agents, diabetes drugs, and OTC drugs. It serves dispensing pharmacies, clinics, DPC hospitals, hospitals, and others. The company was founded in 1929 and is headquartered in Osaka, Japan.

1,121 Employees
Last Reported Date: 06/25/14
Founded in 1929

sawai pharmaceutical co ltd (4555) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

sawai pharmaceutical co ltd (4555) Key Developments

Sawai Pharmaceutical Co. Ltd. Provides Dividend Guidance for the Year Ending March 31, 2015; Reports Consolidated Earnings Results for the Nine Months Ended Dec. 31, 2014; Provides Earnings Guidance for the Year Ending March 31, 2015

Sawai Pharmaceutical Co. Ltd. provided dividend guidance for the year ending March 31, 2015. For the year, the company expects year end dividend of JPY 50.00 per share compared to JPY 50.00 per share a year ago. The company reported consolidated earnings results for the nine months ended Dec. 31, 2014. For the period, the company reported net sales of JPY 80,190 million compared to JPY 67,930 million a year ago. Operating income was JPY 17,398 million compared to JPY 16,997 million a year ago. Ordinary income was JPY 17,348 million compared to JPY 17,126 million a year ago. Net income was JPY 11,705 million compared to JPY 10,833 million a year ago. Diluted net income per share was JPY 318.11 compared to JPY 293.45 a year ago. For the year ending March 31, 2015, the company expects net sales of JPY 106,000 million, operating income of JPY 21,000 million, ordinary income of JPY 20,900 million and net income of JPY 13,500 million or net income per share of JPY 367.28.

Sawai Pharmaceutical Co. Ltd., Q3 2015 Earnings Call, Feb 06, 2015

Sawai Pharmaceutical Co. Ltd., Q3 2015 Earnings Call, Feb 06, 2015

Sawai Pharmaceutical Co. Ltd. to Report Q3, 2015 Results on Feb 06, 2015

Sawai Pharmaceutical Co. Ltd. announced that they will report Q3, 2015 results at 3:00 PM, Tokyo Standard Time on Feb 06, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4555:JP ¥6,880.00 JPY +30.00

4555 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4555.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4555 Industry Range
Price/Earnings 19.5x
Price/Sales 2.5x
Price/Book 2.3x
Price/Cash Flow 19.3x
TEV/Sales 2.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAWAI PHARMACEUTICAL CO LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at